No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels

Diabetes

Volumn 61, Issue 5, 2012, Pages 1291-1296

  Scott, Robert A ^a   Chu, Audrey Y ^b,c   Grarup, Niels ^d,e   Manning, Alisa K ^f   Hivert, Marie France ^g   Shungin, Dmitry ^h,i   Tönjes, Anke ^j   Yesupriya, Ajay ^k   Barnes, Daniel ^a   Bouatia Naji, Nabila ^l,m   Glazer, Nicole L ⁿ   Jackson, Anne U ^o   Kutalik, Zoltán ^p,q   Lagou, Vasiliki ^r,s   Marek, Diana ^p,q   Rasmussen Torvik, Laura J ^t   Stringham, Heather M ^o   Tanaka, Toshiko ^u   Aadahl, Mette ^v   Arking, Dan E ^w   Bergmann, Sven ^p,q   Boerwinkle, Eric ^x   Bonnycastle, Lori L ^y   Bornstein, Stefan R ^z   Brunner, Eric ^aa   Bumpstead, Suzannah J ^ab   Brage, Soren ^a   Carlson, Olga D ^u   Chen, Han ^f   Chen, Yii Der Ida ^ac   Chines, Peter S ^y   Collins, Francis S ^y   Couper, David J ^ad   Dennison, Elaine M ^ae   Dowling, Nicole F ^k   Egan, Josephine S ^u   Ekelund, Ulf ^a   Erdos, Michael R ^y   Forouhi, Nita G ^a   Fox, Caroline S ^b,af   Goodarzi, Mark O ^ac   Grässler, Jürgen ^z   Gustafsson, Stefan ^ag   Hallmans, Göran ⁱ   Hansen, Torben ^d,e,ah   Hingorani, Aroon ^aa   Holloway, John W ^ai   Hu, Frank B ^aj   Isomaa, Bo ^ak,bg   Jameson, Karen A ^ae   Johansson, Ingegerd ⁱ   Jonsson, Anna ^h   Jørgensen, Torben ^v,al   Kivimaki, Mika ^aa   Kovacs, Peter ^am   Kumari, Meena ^aa   Kuusisto, Johanna ^an,bh   Laakso, Markku ^an,bh   Lecoeur, Cécile ^l,m   Lévy Marchal, Claire ^m,ao   Li, Guo ^ap   Loos, Ruth J F ^a   Lyssenko, Valeri ^h   Marmot, Michael ^aa   Marques Vidal, Pedro ^aq   Morken, Mario A ^y   Müller, Gabriele ^z   North, Kari E ^ad   Pankow, James S ^ar   Payne, Felicity ^ab   Prokopenko, Inga ^r,s   Psaty, Bruce M ^as,at   Renström, Frida ^h,aj   Rice, Ken ^as   Rotter, Jerome I ^ac   Rybin, Denis ^au   Sandholt, Camilla H ^d,e   Sayer, Avan A ^ae   Shrader, Peter ^av,aw   Schwarz, Peter E H ^z   Siscovick, David S ^ap   Stančáková, Alena ^an,bh   Stumvoll, Michael ^j   Teslovich, Tanya M ^o   Waeber, Gérard ^ax   Williams, Gordon H ^b,av   Witte, Daniel R ^ay   Wood, Andrew R ^az   Xie, Weijia ^az   Boehnke, Michael ^o   Cooper, Cyrus ^s,ae   Ferrucci, Luigi ^u   Froguel, Philippe ^l,m,ba   Groop, Leif ^h   Kao, W H Linda ^c   Vollenweider, Peter ^ax   Walker, Mark ^bb   Watanabe, Richard M ^bc   Pedersen, Oluf ^d,e,al,bd   Meigs, James B ^av,aw   Ingelsson, Erik ^ag   Barroso, Inês ^ab,be   Florez, Jose C ^av,aw,bf   Franks, Paul W ^h,i,aj   Dupuis, Josée ^f,af   Wareham, Nicholas J ^a   Langenberg, Claudia ^a   more..

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Capital Region   (Denmark)

^e HAGEDORN RESEARCH INSTITUTE   (Denmark)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITÉ DE SHERBROOKE   (Canada)

^h LUND UNIVERSITY   (Sweden)

ⁱ UMEÅ UNIVERSITY   (Sweden)

^j UNIVERSITY OF LEIPZIG   (Germany)

^k NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^l CNRS   (France)

^m UNIV LILLE   (France)

ⁿ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^p UNIVERSITY OF LAUSANNE   (Switzerland)

^q SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^r UNIVERSITY OF OXFORD   (United Kingdom)

^s UNIVERSITY OF OXFORD   (United Kingdom)

^t NORTHWESTERN UNIVERSITY   (United States)

^u NATIONAL INSTITUTE ON AGING   (United States)

^v GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^w JOHNS HOPKINS UNIVERSITY   (United States)

^x UNIVERSITY OF TEXAS   (United States)

^y NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^z DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^aa UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ab WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^ac CEDARS SINAI MEDICAL CENTER   (United States)

^ad IL   (United States)

^ae UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^af FRAMINGHAM HEART STUDY   (United States)

^ag KAROLINSKA INSTITUTE   (Sweden)

^ah UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^ai UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^aj HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ak FOLKHÄLSAN RESEARCH CENTER   (Finland)

^al UNIVERSITY OF COPENHAGEN   (Denmark)

^am UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^an UNIVERSITY OF EASTERN FINLAND   (Finland)

^ao HÔPITAL ROBERT DEBRÉ   (France)

^ap UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^aq UNIVERSITY OF LAUSANNE   (Switzerland)

^ar UNIVERSITY OF MINNESOTA   (United States)

^as UNIVERSITY OF WASHINGTON   (United States)

^at GROUP HEALTH RESEARCH INSTITUTE   (United States)

^au BOSTON UNIVERSITY   (United States)

^av HARVARD MEDICAL SCHOOL   (United States)

^aw MASSACHUSETTS GENERAL HOSPITAL   (United States)

^ax LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^ay STENO DIABETES CENTER   (Denmark)

^az PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^ba IMPERIAL COLLEGE LONDON   (United Kingdom)

^bb NEWCASTLE UNIVERSITY   (United Kingdom)

^bc UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^bd AARHUS UNIVERSITY   (Denmark)

^be UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^bf MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^bg NONE   (Finland)

^bh KUOPIO UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADCY5 GENE; ALLELE; ARTICLE; BODY MASS; GCKR GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GIPR GENE; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TCF7L2 GENE; VPS13C GENE;

BLOOD GLUCOSE; BODY MASS INDEX; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; LIFE STYLE; MOTOR ACTIVITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84860587659     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0973     Document Type: Article

References (28)

1. Qiao Q, Tuomilehto J, Borch-Johnsen K. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia 2003;46(Suppl. 1):M17-M21 (Pubitemid 36543099)
2. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-589
3. Saxena R, Hivert MF, Langenberg C, et al.; GIANT consortium; MAGIC investigators. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010;42:142-148
4. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007;30: 1562-1566 (Pubitemid 46871171)
5. Manson JE, Rimm EB, Stampfer MJ, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991;338:774-778
6. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26:61-69
7. Wareham NJ, Wong MY, Day NE. Glucose intolerance and physical in-activity: the relative importance of low habitual energy expenditure and cardiorespiratory fitness. Am J Epidemiol 2000;152:132-139 (Pubitemid 30463661)
8. Healy GN, Dunstan DW, Shaw JE, Zimmet PZ, Owen N. Beneficial associations of physical activity with 2-h but not fasting blood glucose in Australian adults: the AusDiab study. Diabetes Care 2006;29:2598-2604 (Pubitemid 44912185)
9. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
10. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344: 1343-1350 (Pubitemid 32378388)
11. Franks PW, Mesa JL, Harding AH, Wareham NJ. Gene-lifestyle interaction on risk of type 2 diabetes. Nutr Metab Cardiovasc Dis 2007;17:104-124 (Pubitemid 46240794)
12. Palla L, Higgins JP, Wareham NJ, Sharp SJ. Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol 2010;171:1225-1232
13. Speliotes EK, Willer CJ, Berndt SI, et al.; MAGIC; Procardis Consortium. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937-948
14. Smith PG, Day NE. The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol 1984;13:356-365 (Pubitemid 14004410)
15. Travis RC, Reeves GK, Green J, et al.; Million Women Study Collaborators. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet 2010;375:2143-2151
16. Li S, Zhao JH, Luan J, et al. Physical activity attenuates the genetic pre-disposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med 2010;7: e1000332.
17. Florez JC, Jablonski KA, Bayley N, et al.; Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355:241-250 (Pubitemid 44079339)
18. Jablonski KA, McAteer JB, de Bakker PI, et al.; Diabetes Prevention Program Research Group. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes 2010;59:2672-2681
19. Florez JC, Jablonski KA, Sun MW, et al.; Diabetes Prevention Program Research Group. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab 2007;92:1502-1509 (Pubitemid 46556431)
20. Franks PW, Jablonski KA, Delahanty L, et al.; Diabetes Prevention Program Research Group. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007;50:2451-2460 (Pubitemid 350060645)
21. Kilpeläinen TO, Lakka TA, Laaksonen DE, et al.; Finnish Diabetes Prevention Study Group. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRLwith physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study. Metabolism 2008;57:428-436 (Pubitemid 351178735)
22. Todorova B, Kubaszek A, Pihlajamäki J, et al.; Finnish Diabetes Prevention Study. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 2004;89:2019-2023 (Pubitemid 38619826)
23. Manolio TA, Bailey-Wilson JE, Collins FS. Genes, environment and the value of prospective cohort studies. Nat Rev Genet 2006;7:812-820 (Pubitemid 44413225)
24. Wong MY, Day NE, Luan JA, Chan KP, Wareham NJ. The detection of gene-environment interaction for continuous traits: should we deal with measurement error by bigger studies or better measurement? Int J Epidemiol 2003;32:51-57 (Pubitemid 36503473)
25. Dupuis J, Langenberg C, Prokopenko I, et al.; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-116
26. Stolerman ES, Manning AK, McAteer JB, et al. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. Diabetologia 2009;52:614-620
27. Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007;117:2155-2163 (Pubitemid 47219560)
28. Helgason A, Pálsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007;39: 218-225 (Pubitemid 46184353)